Looks like you’re on the UK site. Choose another location to see content specific to your location
Mylan to complete billion-dollar share repurchase plan
Mylan has announced that it will be completing the $1 billion (GBP 739.39 million) share repurchase plan that its board of directors previously approved.
This decision reflects the continued strong performance the company continues to achieve in terms of its adjusted free cash flow generation, and means Mylan is able to carry on executing on its business strategies while effectively deploying capital and delivering strong shareholder returns.
In addition, following the recent purchase of Abbott's EPD assets, Mylan has received notification that Abbott has sold its remaining 20.3 million shares of Mylan, meaning a potential share overhang has been avoided.
Mylan's chairman Robert Coury said: "We are committed to continuing our dialogue with shareholders and the larger investor community in an effort to continue to optimise Mylan's valuation."
This return of capital to shareholders comes at a time when Mylan is enjoying positive momentum fuelled by the recent approval and launch of several key products, with the firm also harbouring strong growth expectations and a view that its platform is being substantially undervalued at present.
With over 20 years of experience within the consumer market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current consumer roles we have available, you can search for the latest job roles, register your details, or contact the team today.
We have hundreds of jobs available across the Healthcare industry, find your perfect one now.
Stay informed
Receive the latest industry news, Tips and straight to your inbox.
- Share Article
- Share on Twitter
- Share on Facebook
- Share on LinkedIn
- Copy link Copied to clipboard